Cyclopharm Limited (ASX:CYC) Insider David Heaney Purchases 8,874 Shares

Cyclopharm Limited (ASX:CYC) insider David Heaney acquired 8,874 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The shares were purchased at an average price of A$1.50 ($0.93) per share, with a total value of A$13,266.63 ($8,240.14).

Cyclopharm Price Performance

The company has a quick ratio of 4.68, a current ratio of 4.38 and a debt-to-equity ratio of 11.72. The stock has a market capitalization of $219.50 million, a price-to-earnings ratio of -20.32 and a beta of 0.70.

Cyclopharm Company Profile

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.